Open AccessP1324: A RISK‐BASED STRATEGY FOR THE USE OF LETERMOVIR IN CMV‐POSITIVE RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
Author(s) -
Beauvais D.,
Sourisseau M.,
Béhal H.,
Alfandari S.,
Simon N.,
Faure E.,
YakoubAgha I.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000848160.85133.ee
Subject(s) - medicine , transplantation , hematopoietic cell , disease , retrospective cohort study , haematopoiesis , stem cell , biology , genetics